Research Project
Grant-in-Aid for Young Scientists (B)
It is desirable to develop a therapeutic means to down-modulate immune responses in anantigen-specific manner without causing systemic immune suppression. We tried the immune regulationof pathogenic CD8+ T cells by mouse ES cell-derived dendritic cells (ES-DCs) expressing both antigenand immunosuppressive molecule, such as TRAIL or PD-L1. In this period, we brought in the C-proteininduced myositis, CIM, which was disease model caused by pathogenic CD8+ T cells. The functionalES-DCs expressing immunosuppressive molecule was prepared. These ES-DCs may prevent pathogenicCD8+ T cells-derived autoimmune disease.
All 2013 2012 2011
All Journal Article (18 results) (of which Peer Reviewed: 9 results) Presentation (8 results)
Ann. Rheum. Dis
Volume: 72 Issue: 6 Pages: 1100-1102
10.1136/annrheumdis-2012-202768
科学評論社 (東京)
Volume: 54号 Pages: 238-242
Clinical Neuroscience
Volume: 30(3) Pages: 296-300
医学のあゆみ
Volume: 別冊 Pages: 53-57
40019000692
Seminars in Immunopathology
Volume: 33 Issue: 6 Pages: 603-612
10.1007/s00281-011-0263-y
120005199485
FEBS J
Volume: 278(8) Issue: 8 Pages: 1358-66
10.1111/j.1742-4658.2011.08055.x
Br J Cancer
Volume: 104 Issue: 2 Pages: 300-307
10.1038/sj.bjc.6606052
Cancer Science
Volume: 102 Issue: 1 Pages: 71-78
10.1111/j.1349-7006.2010.01780.x
Volume: 239(1) Pages: 53-57
リウマチ科
Volume: 45(3) Pages: 285-290
免疫疾患-疾患モデルの作製と利用
Pages: 92-97
Semin Immunopathol
Volume: 33(6) Pages: 603-612
Volume: 278(8) Pages: 1358-1366
Volume: 104(2) Pages: 300-307
Cancer Sci
Volume: 102(1) Pages: 71-78
10029288476
Volume: 1 Pages: 92-97
Volume: 46(5) Pages: 467-471